RSS
“I think that changed the way generics operate; since it’s tougher for them to make a lot of money, they’ve gotten even more aggressive.” From the brand perspective “it’s almost impossible to get a settlement that sticks” and that presents challenges across the business.
Continue Reading →“Knowing when to get outside support is the philosophy throughout the company, not just the legal department. We also have what we call a kitchen cabinet of outside business development advisors who each bring a different perspective to the table and help keep us on target”
Continue Reading →“What’s really needed is a process that keeps options alive so that there’s more than just a “go” or “no-go” choice in a certain phase”.
Continue Reading →Following a number of appeals, Merck wins the U.S. Supreme Court case around the ownership terms of brain-cancer drug Temodar patent.
Continue Reading →‘But we’re not there to steal information from you, from the little company. We’re there to use the information and help us decide about the interest of this investment opportunity.’
Continue Reading →